Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
4.070
+0.220 (5.71%)
At close: Nov 21, 2024, 4:00 PM
4.180
+0.110 (2.70%)
After-hours: Nov 21, 2024, 4:03 PM EST

Eledon Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-21.22-116.54-87.97-34.51-22.81-16.01
Upgrade
Depreciation & Amortization
0.370.370.370.20.180.18
Upgrade
Asset Writedown & Restructuring Costs
--48.65--1.87
Upgrade
Loss (Gain) From Sale of Investments
-2.54-1.2----
Upgrade
Stock-Based Compensation
8.256.558.157.93.171.31
Upgrade
Other Operating Activities
-31.8176.21--2.354.43-
Upgrade
Change in Accounts Payable
9.8-2.62.082.14-0.04-1.39
Upgrade
Change in Other Net Operating Assets
-0.26-2.320.29-2.3-0.140.19
Upgrade
Operating Cash Flow
-37.42-39.53-28.42-28.91-15.21-13.86
Upgrade
Cash Acquisitions
----11.04-
Upgrade
Investment in Securities
-12.86-45.29----
Upgrade
Investing Cash Flow
-12.86-45.29--11.04-
Upgrade
Issuance of Common Stock
53.3633.02-014.389.68
Upgrade
Repurchase of Common Stock
-----0.03-
Upgrade
Other Financing Activities
----0.45--
Upgrade
Financing Cash Flow
53.3633.02--0.45109.589.68
Upgrade
Net Cash Flow
3.08-51.8-28.42-29.36105.4-4.18
Upgrade
Free Cash Flow
-37.42-39.53-28.42-28.91-15.21-13.86
Upgrade
Free Cash Flow Per Share
-0.97-1.61-1.99-1.95-10.48-21.14
Upgrade
Levered Free Cash Flow
-23.2-24.47-13.85-15.33-4.01-8.64
Upgrade
Unlevered Free Cash Flow
-23.2-24.47-13.85-15.33-4.01-8.64
Upgrade
Change in Net Working Capital
-9.864.52-2.480.39-0.941.27
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.